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SUMMARY: The synthesis of 1-monoacylglycerols of selected unsaturated fatty acids and their antimicrobial 
and cytotoxicity activity is reported in the present study. The monoacylglycerols of fatty acids like undecenoic, 
oleic, linoleic and erucic acids were prepared by chemical esterification with solketal followed by deprotection. 
Fatty acids like alpha linolenic, gamma linolenic and ricinoleic acids were initially isolated from natural sources 
and further enriched in their respective methyl ester forms. The monoacylglycerols of ricinoleic and linole-
nic acid methyl esters were prepared by enzymatic transesterification with solketal using lipase from Candida 
antarctica followed by deprotection. The synthesized 1-monoacylglycerols were purified and characterized by 
spectral studies. The antimicrobial activity revealed that the monoacylglycerol of gamma linolenic acid was the 
most effective antibacterial followed by the monoacylglycerols of undecenoic and alpha linolenic acids. In the 
cytotoxicity assay against five cell lines, all the monoacylglycerols exhibited moderate activity but the activity 
was best against MCF7 Human Breast Adenocarcinoma cell lines.
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RESUMEN: Síntesis, caracterización y evaluación de 1-monoacilgliceroles de ácidos grasos insaturados como 
potenciales lípidos bioactivos. La síntesis de 1-monoacilgliceroles de ácidos grasos insaturados seleccionados y 
su actividad antimicrobiana y citotoxicidad se describen en el presente estudio. Los monoacilgliceroles de ácidos 
grasos como los ácidos undecenoico, oleico, linoleico y erúcico se prepararon mediante esterificación química 
con solketal seguido de desprotección. Los ácidos grasos como el alfa-linolénico, gamma-linolénico y ricinoleico 
se aislaron inicialmente de fuentes naturales y se enriquecieron aún más en sus respectivos ésteres metílicos. Los 
monoacilgliceroles de los ésteres metílicos de los ácidos ricinoleico y linolénico se prepararon mediante trans-
esterificación enzimática con solketal utilizando lipasa de Candida antárctica seguido de desprotección. Los 
1-monoacilgliceroles sintetizados se purificaron y caracterizaron mediante estudios espectrales. La actividad 
antimicrobiana mostró que el monoacilglicerol del ácido gamma-linolénico fue el antibacteriano más eficaz 
seguido del monoacilglicerol de los ácidos undecenoico y alfa-linolénico. En el ensayo de citotoxicidad contra 
cinco líneas celulares, todos los monoacilgliceroles mostraron una actividad moderada, pero la actividad fue 
mejor contra las líneas celulares de adenocarcinoma de mama humano MCF7.
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1. INTRODUCTION
Structured lipids have gained importance in spe-
cialty foods which include modified lipids ranging 
from glycerides to phospholipids and are produced 
for specific food, nutritional and biomedical applica-
tions. (Osborn and Akoh 2002). Among these struc-
tured lipids, monoacylglycerols (MAGs) are well 
known for their use as emulsifying agents and as car-
riers of nutrients in food applications for improved 
bioavailability (Lu et al., 2017). In addition to this, 
MAGs are also known for their antimicrobial activ-
ity and are reported to exert stronger antimicrobial 
activity than their corresponding free fatty acids 
(Kabara et al., 2005). In light of the emerging anti-
microbial resistance towards conventional antimi-
crobials, interest in the development of new agents 
which are non-toxic or less toxic in nature led to 
interest in alternative agents. In this context, lipids 
and their derivatives are receiving renewed interest as 
they are obtained from natural sources and are gen-
erally regarded as safe and non-toxic (Littich et al., 
2017). Among the bioactive structured lipids, MAGs 
are known to play an important role as drug carriers 
in formulations in the cosmetic and pharmaceutical 
industries (Pawongrat et al., 2008). Among the vari-
ous MAGs studied, 1-monolaurin is the only MAG 
which is widely studied and is reported to exert anti-
microbial effect as studied by Jon J.Kabara’s group 
and other researchers (Kabara et  al., 1972; Altieri 
et al., 2009). The industrial production of MAGs is 
carried out by the glycerolysis of natural fats and oils. 
However, the preparation of structured MAGs can 
be achieved with different methods by chemical and 
enzymatic processes which are reported in the litera-
ture. These include the glycerolysis of triacyglycerols 
with glycerol in the presence of inorganic catalysts 
at high temperatures (Sontag 1982), the reaction of 
fatty acids and glycidol catalyzed by chromium-fatty 
acid complexes (Janis et al., 2000) and by enzymatic 
methods (Bornscheuer 1995).
Research in this area is gaining importance 
because of the potential benefits of MAGs such as 
their biocompatibility and biodegradable nature. 
There are reports on the higher activity of unsatu-
rated fatty acids compared to saturated fatty acids 
on some microbial strains (Zheng et  al., 2005). It 
was recently reported that long-chain poly unsatu-
rated fatty acids have potential as topical antimi-
crobials against Gram-positive bacteria along with 
anti-inflammatory properties (Desbois et al., 2013). 
Though there are reports on the antimicrobial 
studies of MAGs of some unsaturated fatty acids, 
there are no reports on the cytotoxic evaluation of 
MAGs of unsaturated fatty acids. The objective 
of the present study is to prepare and characterize 
the MAGs of selected unsaturated fatty acids and 
examine their antimicrobial and cytotoxic activi-
ties which could expand their application in food 
and biomedical applications. The unsaturated fatty 
acids namely undecenoic, oleic, ricinoleic, linoleic, 
alpha linolenic, gamma linolenic and erucic acids 
were selected for the study. Undecenoic acid is well 
known for its antifungal activity and also for its 
application in pharmaceutical and cosmetic prod-
ucts (Pierard et al., 1997). Oleic acid is known for 
its emollient properties and is reported to help as 
a carrier for medicinal and cosmetic ingredients for 
delivery through the skin (Aarti et al., 1995). 
Linoleic acid is a nutritionally important fatty 
acid whose intake is reported to have inverse 
effects on heart diseases and cholesterol levels 
(Maryam  et  al.,  2014). The polyunsaturated fatty 
acids (PUFAs) ALA and GLA are nutraceutically 
and physiologically important fatty acids which are 
known for their numerous nutritional and health 
benefits. (Flider, 2005; Nguemeni et al., 2013). Erucic 
acid is mainly obtained from mustard oil, high erucic 
acid rapeseed oil and is widely known for its indus-
trial applications. Ricinoleic acid, a hydroxyl group 
containing fatty acid obtained from castor oil is 
known for many medicinal applications (Pabis´ et al., 
2016). Owing to the beneficial properties of unsatu-
rated fatty acids, the study of 1-MAGs of these fatty 
acids could be of interest as they can have potential 
bioactive applications. Hence the present study was 
aimed to investigate and evaluate the synthesis and 
antimicrobial and cytotoxicity activity of 1-MAGs 
from these selected unsaturated atty acids. 
2. MATERIALS AND METHODS
2.1. Materials and instruments
Oleic and linoleic acids were purchased from TCI 
chemicals, India. Solketal, erucic acid and borage oil 
were purchased from Sigma Aldrich. Eripupae were 
obtained from the Central Silk Board, Bengaluru, 
India. Castor oil was purchased from a local 
 market. N,N’-Dicyclohexyl carbodiimide (DCC), 
4-Dimethylaminopyridine (DMAP) were obtained 
from SRL. Penicillin and Streptomycin were used 
as standard drugs. All solvents were purchased from 
Merck and used without further purification. The 
proton NMR spectra were recorded on a Varian 
400 MHz instrument and TMS was used as internal 
standard. Mass spectra were recorded using electron 
spray ionization on a Waters e2695 Separator mod-
ule (Waters, Milford, MA, USA) mass spectrometer. 
IR spectra were recorded in dichloromethane on a 
Perkin-Elmer Fourier transform (FT)-IR Spectrum 
BX instrument (Model: Spectrum BX; Connecticut, 
USA). All the synthesized products were purified 
by silica gel (60– 120 mesh) column chromatogra-
phy (Acme Synthetic Chemicals, Mumbai, India) 
and identified by thin-layer chromatography (TLC). 
TLC was performed on pre-coated silica gel 60 F254 
from Merck (Darmstadt, Germany).
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2.2. Isolation and enrichment of fatty acids from 
natural sources
2.2.1. Preparation of PUFA fractions from oils 
For gamma linolenic acid and alpha linolenic 
acid, borage oil and eri silkworm oil were chosen as 
substrates. Both silkworm oil and borage oils were 
converted to fatty acid methyl esters according to 
the reported method. Briefly, the oils were refluxed 
in a 2% sulfuric acid-methanol reagent for 3 hours. 
After complete conversion as monitored by TLC, 
the solvent was evaporated and the contents were 
transferred to a separating funnel and ethyl acetate 
was added and washed with distilled water until neu-
tral. The organic phase was dried over anhydrous 
sodium sulphate and concentrated to obtain the 
fatty acid methyl esters (Christie 1982). The result-
ing methyl esters were subjected to urea crystalliza-
tion for enrichment of PUFA following previously 
reported protocols (Kaki et al., 2014).
2.2.2. Isolation of pure methyl ricinoleate from 
castor oil
Castor oil (15 g) was converted to methyl esters 
using 300 mL of 2%-sulphuric acid methanol reagent 
for 3 hours at 75 °C with magnetic stirring. After com-
plete conversion as monitored by TLC, the solvent 
was evaporated and the contents were transferred to 
a separating funnel and ethyl acetate (150 mL x2) was 
added and washed with distilled water until neutral. 
The organic phase was dried over anhydrous sodium 
sulphate and concentrated to obtain fatty acid methyl 
esters. The methyl esters (10 g) were separated into 
pure methyl ricinoleate (9.04 g; 90% yield) and non-
hydroxy fatty acid methyl esters following a reported 
protocol (Berdeaux et  al., 1997). Castor oil FAME 
(10 g) was shaken with 300 mL hexane and 150 mL 
90% aq. methanol. After the layers were separated, 
the methanolic phase was collected and the hexane 
phase was washed again with fresh 90% aq. methanol 
(100 mL). The two fractions were monitored by TLC 
for purity of methyl ricinoleate. Finally, methanol was 
evaporated from the fraction which showed only the 
presence of methyl ricinoleate and ethyl acetate was 
added followed by brine and water wash. Later the 
methyl ricinoleate fraction was dried over anhydrous 
sodium sulphate and the solvent was evaporated to 
yield pure methyl ricinoleate with 90% yield (9.04 g). 
The castor oil methyl esters and enriched methyl 
ricinoleate samples were analyzed by gas chromatog-
raphy for determining the fatty acid composition.
2.2.3. Gas chromatography
Two temperature programs were employed for 
the gas chromatographic (GC) analysis. For nor-
mal fatty acid methyl esters, GC was performed 
on an Agilent 6890 gas chromatograph equipped 
with a flame ionization detector. The column used 
was a DB-225 with a length of  30 m, 0.25 mm 
i.d and 25 μm film thickness. The carrier gas was 
nitrogen at a flow rate of  1 mL/min. The oven pro-
gramming was as follows: 160 °C for 2 minutes, 
raised to 230 °C at a rate of  5 °C/min and held at 
230 °C for 20 minutes. The injector and detector 
temperatures were maintained at 220 and 250 °C, 
respectively. For castor oil fatty acid methyl esters, 
GC was performed using an Agilent 6890 gas chro-
matograph coupled with a FID. A HP-1 capillary 
column (30 m x 0.25 mm x 0.25 μm, (Agilent) was 
used with a column temperature program of  160°C 
for 2 min, raised at 10 °C/min to 300 °C and held 
for 20 min at 300 °C. The injector temperature was 
280 °C with a split ratio of  50:1. The carrier gas 
was nitrogen at a flow rate of  1 mL/min. The detec-
tor temperature was 300 °C with air and hydrogen 
flow rates of  300 mL/min and 30 mL/min, respec-
tively. The fatty acids were identified by compar-
ing the retention times with those of  standard fatty 
acid methyl esters. 
2.3. Synthesis of 1-monoacylglycerols of unsaturated 
fatty acids
2.3.1. Synthesis of 1-monoacylglycerols
The synthesis of 1-monoacylglycerols was car-
ried out in two steps following a reported protocol 
with slight modifications (Yang et al., 2012).
2.3.2. Esterification of solketal with fatty acids
The esterification of oleic acid with solketal 
is described as an example. In a 100 mL round- 
bottomed flask, solketal (0.79 g, 0.006 moles) was 
dissolved in dichloromethane (15 mL) and DMAP 
(0.2  eq, 0.12 g) was added at 0 ºC. A mixture of 
DCC (1 eq, 1.03 g) and oleic acid (1 eq, 1.41 g, 
0.005  moles) was added and dissolved in 20 mL 
dichloromethane. The ice bath was removed and 
the reaction was stirred at room temperature for 
24h. After 24 h, the reaction mixture was filtered to 
remove the precipitate. The filtrate containing the 
product was washed with saturated aqueous sodium 
bicarbonate (50 mL) and water (3 x 75 mL) and the 
organic layer was dried over anhydrous sodium sul-
phate and concentrated by rotary evaporation at 
45 ºC to obtain the crude product. The crude prod-
uct was purified by silica gel (60–120 mesh) column 
chromatography using hexane and ethyl acetate 
gradient to obtain pure acetonide at a 70% yield 
(1.39  g). The product was concentrated and char-
acterized using 1H-NMR, IR and mass spectral 
data. A similar protocol was followed for the esteri-
fication of undecenoic, linoleic and erucic acids to 
obtain the corresponding acetonides.
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2.3.3. Transesterification of ricinoleic acid methyl 
ester with solketal 
Ricinoleic acid methyl ester (1.5 g; 00 4.8mmol) 
and solketal (0.69 g; 5.28 mmol) were mixed together. 
The lipase from C. antarctica (10% to wt of substrates) 
was added and the reaction mixture was magnetically 
stirred at 60 ºC under vacuum. After maximum con-
version as observed by TLC, ethyl acetate was added 
to the reaction medium and the lipase was separated 
by filtration. The filtered lipase was washed with 
ethyl acetate and the combined ethyl acetate filtrate 
was evaporated to obtain the crude reaction product. 
The crude product was purified by column chroma-
tography on silica gel (60–120 mesh) using a gradient 
of hexane and ethyl acetate to obtain pure acetonide 
at a 73% yield (1.36 g). Similarly, the ALA methyl 
ester and GLA methyl esters were transesterified with 
solketal to obtain the respective acetonides at 45 and 
61% yields, respectively.
2.3.4. Spectral data of acetonides
(2, 2-dimethyl-1, 3-dioxolan-4-yl) methyl undec-
10-enoate (1a); Yield: 60%; 1H NMR (400 MHz, 
CDCl3) δ: 1.31 (d, J = 15.7 Hz,-CH3-, 6H), 1.50 – 
1.34 (m,-CH2-, 6H), 1.69 – 1.55 (m, -CH2-, 2H), 
2.08 – 1.99 (m, CH2-, 2H), 2.34 (t, J = 15.2 Hz,-CH2-, 
2H), 3.74 (dd, J = 8.4Hz, 6.2 Hz,-CH-, 1H), 4.13 – 
4.05 (m,-CH2- , 2H), 4.17 (dd, J = 11.5Hz, 4.7 Hz, 
-CH-, 1H), 4.31 (m, -CH-, 1H), 5.06 – 4.89 (m,-CH2-, 
2H), 5.81 (m, -CH-, 1H); IR (cm-1): 1741cm-1, 2928, 
2855cm-1, 3076cm-1 MS: m/z 321.33 [M+23] .
(2, 2-dimethyl-1, 3-dioxolan-4-yl) methyl ole-
ate (1b); Yield: 70%; 1H NMR (400 MHz, CDCl3) 
δ: 0.89 (t, J = 6.72Hz, CH3, 3H), 1.34 - 1.26 (m, 
(CH2)10, 20H), 1.63 - 1.58 (m, CH2, 2H), 2.03 - 1.98 
(m, (CH2)2, 4H), 2.36 - 2.32 (t, J = 7.4 Hz, CH2, 
2H), 3.75 - 3.71 (m, CH, 1H), 4.18 - 4.05 (m, CH, 
CH2, 3H), 4.34 – 4.28 (m, CH, 1H), 5.38 - 5.30 
(m, (=CH)2, 2H); MS: m/z 419 [M+23]
(9Z,12Z)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl 
octadeca-9,12-dienoate (1c); Yield: 90 %; 1H NMR 
(400 MHz, CDCl3) δ: 0.89 (t, J = 8.2 Hz, CH3, 3H), 
1.41 – 1.18 (m,(CH2)9, 18H), 1.48 – 1.40 (m, CH2, 2H), 
1.70 – 1.59 (m, CH2, 2H), 2.05 (q, J = 6.8 Hz, CH2, 
4H), 2.35 (t, J = 6.95 Hz, 6.4 Hz, CH2, 2H), 2.77 (t, J = 
6.5 Hz, 2H), 3.74 (m, CH, 1H), 4.38 – 4.00 (m, (CH2)2, 
4H), 5.49 – 5.24 (m ,( CH)4, 4H); IR: 1735cm-1, 
2875.50 cm-1, 2966.43 cm-1; MS: m/z = 417.47 [M+23]
(6Z,9Z,12Z)-(2,2-dimethyl-1,3-dioxolan-4-yl)
methyl octadeca-6,9,12-trienoate (1d); Yield: 61%; 
1H NMR (400 MHz, CDCl3) δ: 0.89 (t, J = 6.91 Hz, 
CH3, 3H), 1.47 – 1.31 (m, (CH2)6, 12H), 1.74 – 1.59 
(m, CH2, 2H), 2.11-2.03 (m, (CH2)2, 4H), 2.36 (t, J 
= 7.51 Hz, CH2, 2H), 2.96 – 2.63 (m, (CH2)2, 4H), 
3.75-3.71 (m, CH, 1H), 4.44 – 3.98 (m, (CH2)2, 4H), 
5.49 – 5.25 (m, (CH)6, 6H). IR: 1737 cm-1, 2859 cm-1, 
2929 cm-1, 3013 cm-1; Mass: m/z 415.32 [M+23] 
(9Z,12Z,15Z)-(2,2-dimethyl-1,3-dioxolan-4-yl)
methyl octadeca-9,12,15-trienoate (1e); Yield: 45%; 
1H NMR (400 MHz, CDCl3) δ 0.97 (t, J = 7.51 Hz, 
CH3, 3H), 1.34 – 1.24 (m, (CH2)6, 12H), 1.65 – 1.61 
(m, CH2, 2H), 2.09 – 2.03 (m, CH2, 2H), 2.34 (t, J 
=7.51 Hz, CH2, 2H), 2.86 – 2.73 (m, (CH2)2, 4H), 
3.76 – 3.72 (m, CH2, 2H), 4.20 – 4.05 (m, (CH2)2, 
4H), 4.37 – 4.29 (m, CH, 1H), 5.44 – 5.27 (m, (=CH)6, 
6H); IR: 1265.58 cm-1, 1736.82 cm-1, 2856.53 cm-1, 
2930 cm-1, 3054.80 cm-1; Mass: m/z 415.28 [M+23]
(Z)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl docos-
13-enoate (1f); Yield: 82%; 1H NMR (400  MHz) 
δ: 0.89 (t, J = 6.78 Hz, CH3, 3H) , 1.36 – 1.22 
(m, (CH2)16, 32H), 1.66 – 1.60 (m, CH2, 2H), 1.98 
- 2.06 (m, CH2, 4H), 2.34 (t, J = 7.58 Hz, CH2, 3H), 
3.69 - 3.78 (m, CH, 1H), 4.37 – 3.99 (m, (CH2)2, 4H), 
5.39 – 5.31 (m, (=CH)2, 2H); IR: 1733cm-1, 2857 
cm-1, 2927 cm-1, 3018 cm-1; MS: m/z 475 [M+23]
(Z)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl 
12-hydroxyoctadec-9-enoate (1g); Yield: 73%; 1H 
NMR (500 MHz, CDCl3) δ 0.88 (t, J =6.90 Hz, 
CH3, 3H), 1.58 – 1.53 (m, (CH2)10, 20H), 2.19 – 2.15 
(m, (CH2)5, 10H), 2.34 (t, J = 7.58 Hz, CH2, 2H), 
3.75 – 3.72 (m, CH, 1H), 4.20 – 4.03 (m, CH2, 2H), 
4.35 – 4.27 (m, CH, 1H), 5.57 – 5.37 (m, (CH)2, 
2H); IR: 1216 cm-1, 1733cm-1, 2859cm-1, 2930cm-1, 
3018cm-1, 3348cm-1; Mass: m/z 435.67 [M+23].
2.3.5. Hydrolysis of acetonide to 
1-monoacylglycerols
The acetonide of oleic acid (1.25 g, 0.003 moles) 
dissolved in methanol (40 mL) in a round-bottomed 
flask was placed in an ice bath. To this cooled mix-
ture, 2 M aqueous hydrochloric acid (2.4 mL, 1.6 eq) 
were added in one portion. After 15 min, the ice bath 
was removed and the reaction mixture was stirred for 
5 hours at room temperature (20 ºC) while monitor-
ing by TLC at every hour. When the conversion was 
complete (5 h), the reaction mixture was diluted with 
200 mL of diethyl ether, transferred to a separating 
funnel and washed with 200 mL of saturated aque-
ous sodium bicarbonate and extracted with diethyl 
ether (3 x 150 mL). The organic phases containing the 
product were dried over sodium sulphate and concen-
trated by rotary evaporation at 45 ºC. The crude prod-
uct was purified by silica gel column chromatography 
using a gradient of hexane and ethyl acetate to obtain 
the corresponding MAG at a 71% yield (0.8 g). The 
purified product was characterized using 1H-NMR, 
IR and mass spectral data. The other acetonides in the 
study were also hydrolyzed following the same meth-
odology to obtain corresponding monoglycerides.
2.3.6. Spectral data of 1-MAGs
2,3-dihydroxypropyl undec-10-enoate (2a; UDA-
MAG): Yield: 73%; H1-NMR (400 MHz, CDCl3) 
δ: δ 1.49 – 1.18 (m, -CH2, 12H), 2.05 – 2.00 
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(m, -CH2-, 2H), 2.45 – 2.27 (m, -CH2-, 2H), 3.62 – 
3.58 (m, -OH, 1H), 3.71 – 3.68 (m, -OH, 1H), 3.94 – 
3.90 (m, CH, 1H), 4.23 – 4.12 (m, -CH2-, 2H), 
5.05 – 4.87 (m, -C-H-, 2H), 5.86 – 5.74 (m, -C-H-, 1H); 
IR: 1729cm-1 , 2928cm-1, 2856cm-1, 3015cm-1, 
3407cm-1; MS: m/z 281.38 [M+23]
2, 3-dihydroxypropyl oleate (2b; Oleic-MAG): 
Yield: 71%; H1-NMR (400 MHz, CDCl3) δ: 0.89 
(t, J =6.84 Hz, CH3, 3H), 1.30 – 1.26 (m, (CH2)20, 
20H), 1.64 – 1.59(m, CH2, 2H), 2.03 -1.98 (m, 
(CH2)2, 4H), 2.37 - 2.33 (t, 7.59 Hz, CH2, 2H), 3.71 
- 3.57 (m, CH2, 2H), 3.95 -3.82 (m, CH, 1H), 4.22 – 
4.12 (m, CH2, 2H), 5.38 – 5.30 (m, (=CH)2, 2H); IR 
(cm-1): 1730 cm-1, 2851 cm-1, 2926 cm-1, 3010 cm-1, 
3404 cm-1; MS: m/z 379.46 [M+23]
(9Z, 12Z)-2, 3-dihydroxypropyl octadeca-9, 
12-dienoate (2c; Linoleic-MAG): Yield: 72%; 
H1-NMR (400 MHz, CDCl3) δ: 0.89 (t, 8.2 Hz, 
CH3, H), 1.24-1.43 (m, (CH2)7, 14H), 1.59-1.69 (m, 
CH2, 2H), 2.02-2.11(m, (CH2)2, 4H), 2.35 (t, J = 7.6 
Hz, CH2, 2H), 2.77 (t, J = 6.5 Hz, CH, 1H), 3.58-
3.72 (m, CH2, 2H), 3.82-3.96(m, CH, 1H) ,4.130 - 
4.23 (m, CH2, 2H), 5.30 - 5.42 (m, (CH)4, 4H); IR: 
1731.15 cm-1, 2856.27 cm-1, 2927.96 cm-1, 3010.51 
cm-1, 3403.57 cm-1; Mass: m/z 377.41 [M+23]
(6Z, 9Z, 12Z)-2, 3-dihydroxypropyl octadeca-6, 9, 
12-trienoate (2d; GLA-MAG): Yield: 76%; 1H NMR 
(400 MHz, CDCl3) δ: 0.89 (t, J = 6.9 Hz, 3H), 1.47 
– 1.22(m, (CH2)4, 8H), 1.73 – 1.60 (m, CH2, 2H), 
2.11-2.10 (m, (CH2)2, 4H), 2.37 (t, 7.33 Hz, CH2, 
2H), 2.89–2.72 (m, (CH2)2, 4H), 3.97-3.56 (m,CH, 
CH2, 3H), 4.23-4.12 (m, CH2, 2H), 5.49 – 5.23 
(m, (CH)6, 6H); IR: 1737 cm-1, 2857 cm-1, 2927 cm-1, 
3011 cm-1, 3382 cm-1; Mass: m/z 375.45 [M+23].
(9Z, 12Z, 15Z)-2,3-dihydroxypropyl octa-
deca-9,12,15-trienoate (2e; ALA-MAG): Yield: 72%; 
1H NMR (400 MHz, CDCl3) δ : 0.97 (t, 7.47Hz, 
CH3, 3H), 1.41 – 1.27 (m, (CH2)4, 8H), 1.64 – 1.60 
(m, CH2, 2H), 2.11 – 2.03 (m, (CH2)2, 4H), 2.35 
(t, 7.47 Hz, CH2, 2H), 2.90 – 2.72 (m, (CH2)2, 4H), 
3.78 – 3.50 (m, CH2, 2H), 4.00 – 3.86 (m, CH, 1H), 
4.22 – 4.13 (m, CH2, 2H), 5.50 – 5.18 (m, (CH)6, 
6H); IR: 1265.18 cm-1, 1729 cm-1, 2928.70 cm-1, 
3056.94 cm-1, 3383.57 cm-1; Mass: m/z 375.25 [M+23]
(Z)-2,3-dihydroxypropyl docos-13-enoate 
(2f; Erucic-MAG): Yield: 90%; 1H NMR (500 
MHz) δ 0.88 (t, J = 6.9 Hz, CH3, 3H), 1.38 – 1.20 
(m, (CH2)14, 28H), 1.60-1.66 (m, CH2, 2H), 1.99 - 
2.01 (m, (CH2)2, 4H), 2.35 (t, J = 7.6 Hz, CH2, 2H), 
3.72 – 3.58 (m, CH2, 2H), 3.96 – 3.90 (m, CH, 1H), 
4.18 (m, CH2, 2H), A5.50 – 5.09 (m, (=CH)2, 2H); 
IR: 1730 cm-1, 2856 cm-1, 2927 cm-1, 3021 cm-1, 3418 
cm-1; Mass: m/z = 435 [M+23]
(Z)-2,3-dihydroxypropyl 12-hydroxyoctadec-
9-enoate (2g; Ricinoleic-MAG): Yield: 80%; 1H 
NMR (400 MHz, CDCl3) δ 0.89 (t, J = 6.8 Hz, CH3, 
3H), 1.41 – 1.22 (m, (CH2)8, 16H), 1.47 (t, J = 6.0 
Hz, CH2, 2H), 1.69 – 1.57 (m, CH2, 2H), 2.08 – 2.03 
(m, CH2, 2H), 2.21 (t, J = 6.3 Hz, CH2, 2H), 2.35 
(t, 7.45 Hz, CH2, 2H), 3.66 – 3.56 (m, CH2, 2H), 
3.91 – 3.98 ( m, CH, 1H), 3.96 – 3.91 (m, CH, 1H), 
4.23 – 4.13 (m, 2H, 2H), 5.63 – 5.32 (m, (=CH)2, 
2H); IR: 1216 cm-1, 1728 cm-1, 2858 cm-1, 2929 cm-1, 
3017 cm-1, 3389 cm-1; Mass: m/z 395.22 [M+23].
2.4. Antimicrobial and cytotoxic studies
2.4.1. Antimicrobial activity
The in vitro antibacterial activity of the newly 
synthesized compounds was studied against the 
bacterial strains, Bacillus subtilis (MTCC 441), 
Staphylococcus aureus (MTCC 96), Staphylococcus 
epidermidis and Gram-negative organisms viz 
Escherichia coli (MTCC 443), Pseudomonas aeru-
ginosa (MTCC 741), and Klebsiella pneumoniae 
(MTCC 618), according to the Agar Well Diffusion 
Method (Linday 1962). The Nutrient Agar (NA) 
medium was suspended in distilled water (28 g in 
1000 mL) and heated to boiling until it was dis-
solved completely. The medium and Petri dishes 
were autoclaved at a pressure of 15 psi for 20 min. 
The agar well bioassay was employed for testing 
the antibacterial activity. The medium was poured 
into sterile Petri dishes under aseptic conditions in 
a laminar air flow chamber. When the medium in 
the plates solidified, 0.5 mL of (week old) of cul-
ture from the test organism was inoculated and uni-
formly spread over the agar surface with a sterile 
L-shaped rod. Solutions were prepared by dissolv-
ing the synthesised 1-MAGs in DMSO and different 
concentrations were made. After inoculation, wells 
were scooped out with a 3 mm sterile cork borer 
and the lids were replaced onto the dishes. To each 
well different concentrations of test solutions were 
added. The controls were maintained. The treated 
and control samples were kept at 37° C for 24 h in 
an incubator. Inhibition zones were measured, the 
diameter was calculated in millimeters and the cor-
responding results were tabulated. 
2.4.2. Determination of Minimum Inhibitory 
Concentration
The minimum inhibitory concentrations (MIC) 
of various synthetic compounds were tested against 
three representative Gram-positive organisms viz. 
Bacillus subtilis (MTCC 441), Staphylococcus aureus 
(MTCC 96), Staphylococcus epidermidis and Gram-
negative organisms viz Escherichia coli (MTCC 
443), Pseudomonas aeruginosa (MTCC 741), and 
Klebsiella pneumoniae (MTCC 618) according to 
the Microdilution method recommended by CLSI 
Standard Protocol (Clinical And Laboratory 
Standards Institute 2008) in a liquid medium 
(Nutrient agar) distributed in 96-well plates. Serial 
dilutions of the tested compounds were performed 
(concentrations from 150 μg/mL to 0.97 μg/mL) in 
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a culture medium with final volume of 200 μL and 
each well was seeded with a 50 μL microbial sus-
pension of 0.5 MacFarland density. In each test a 
microbial culture control and a sterility control 
(negative) were prepared. The plates were incubated 
for 24 hours at 37 °C. The lowest concentration 
which inhibited the visible microbial growth was 
considered the MIC (μg/mL) value for the tested 
compound. The minimum inhibitory concentration 
(MIC) values are presented in Table 3. 
2.4.3. Cytotoxicity (MTT Assay) 
The cell viability (MTT test) of the different test 
compounds was assessed following our earlier pub-
lished literature (Kalpana et al., 2018). To describe 
briefly: non-cancerous mammalian cells, CHO-
K1 - ATCC® CCL-61™ (Chinese hamster ovary 
cells) collected from The Centre for Cellular and 
Molecular Biology (CSIR-CCMB), Hyderabad, 
India and Cancer cell lines such as HeLa: Cervical 
cancer (ATCC® CCL2), B16-F10: Mouse skin mel-
anoma (ATCC® CRL 6475™), SKOV3: Human 
ovarian cancer (ATCC® HTB 77™), MCF7: Human 
breast adenocarcinoma (ATCC® HTB-22™) were 
obtained from ATCC (Bethesda, MD, USA). The 
cells were maintained in DMEM supplemented with 
10% FBS, 2 mM L-glutamine, 100 U/mL penicil-
lin, and 100 μg/mL streptomycin at 37 °C in a 5% 
CO2 incubator. The cultured cells were loaded into 
96-well culture plate and allowed to attach properly. 
Each test compound of different concentrations 
ranging from 1 - 50 μM was treated in triplicate 
and incubated for 24 h. Doxorubicin for cancer 
cells and Mitomycin C for CHO cells were used as 
standard drugs for comparison. Then, 0.5 mg/mL 
of  3-(4,5-dimethyl-2-thiazolyl)- 2,5-diphenyl-2H- 
tetrazolium bromide (MTT) were added and incu-
bated for 3 h. To each well, DMSO (100 μL) was 
added to dissolve the insoluble formazan crystals 
and the absorbance of the plates was measured using 
a Synergy H1Multi- Mode Plate Reader, USA.
2.5. Statistical analysis
Statistical analysis was carried out using Graph 
Pad Prism version 6.04 for Windows, Graph Pad 
Software, San Diego. The data were analyzed with 
unpaired Student’s t-test, followed by ‘‘One-way 
ANOVA’’ by the Dunnett’s multiple comparisons 
test. 
3. RESULTS AND DISCUSSION
3.1. Synthesis of 1-MAGs of unsaturated fatty acids
This study was intended to evaluate the anti-
microbial and cytotoxic behavior of the 1-mono-
acylglycerols of selected unsaturated fatty acids. 
Among the selected fatty acids, GLA and ALA were 
obtained from urea complexation from borage and 
eri silkworm oils, respectively, whereas other fatty 
acids were commercially available. Eri silkworm 
oil and borage oil are reported to contain high 
amounts of ALA and GLA, respectively, and hence 
were taken as source oils for PUFAs. Urea complex-
ation was carried out repeatedly to obtain maxi-
mum enrichment of the unsaturated fatty acids in 
the study. Ricinoleic acid was obtained from castor 
oil in pure form by selective extraction of hydroxy 
fatty acid using hexane and aqueous methanol sol-
vent mixtures. Table 1 shows the composition of 
the initial and enriched fractions of unsaturated 
fatty acids.
It can be observed that in both silkworm and 
borage oils, the PUFA fraction was selectively 
enriched with urea complexation, which is usu-
ally the method of choice for PUFA concentration 
(Hayes et al., 1998). For the enrichment of ricinoleic 
acid, solvent fractionation was found to be the best 
and simplest method as it involved the partitioning 
of methyl ricinoleate in an aqueous methanol and 
hexane solvent mixture.
The synthesis of 1-monoacylglycerols of unsatu-
rated fatty acids in the present study was carried out 
in two steps. Initially the fatty acids were esterified 
to solketal employing DCC as the coupling reagent 
and DMAP as the catalyst, which is a wellknown 
methodology for esterification (Yang et  al., 2012) 
at ambient temperatures to obtain the respective 
acetonides at 45-82% yields (Figure 1). Solketal is 
a readily available reagent commercially. Since our 
aim is to prepare 1-monoacyl glycerol, the esterifica-
tion of fatty acids with solketal and deprotection of 
acetonide formed from fatty acid-solketal reaction 
yields the desired 1-monoacyl glycerol with no by-
products. Therefore, we have employed solketal as 
one of the substrates.
As fatty acids like ALA and GLA were enriched 
in their methyl ester form, an enzymatic transesterifi-
cation route was found to be more suitable to avoid 
the hydrolysis of methyl esters and subsequent chem-
ical esterification steps. This has not only reduced the 
number of steps but also provided an opportunity to 
include an enzymatic step which was a simple, mild 
and green methodology. The lipase employed for this 
transesterification was an immobilized lipase from 
Candida antarctica which is well known for its esteri-
fication and transesterification activities in organic 
media (Adlercreutz 2013). Similarly, ricinoleic acid 
which is known to be unstable at ambient tem-
perature was also enriched in its methyl ester form 
which was transesterified with solketal using lipase 
to obtain the corresponding acetonide (Figure 2) at 
a good yield. In the subsequent step, the acetonides 
were hydrolyzed in the presence of aqueous HCl at 
ambient temperature to obtain corresponding mono-
acylglycerols at 71-80% yields.
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The procedures using DCC/DMAP for esterifica-
tion and the hydrolysis of acetonide with HCl were 
mild and the yields were also satisfactory. The prod-
ucts of esterification and deprotection were purified 
by column chromatography and characterized by 
IR, NMR and mass spectral data. The structures of 
the prepared 1-MAGs are shown in Figure 3.
3.2. Biological activity
The synthesized 1-MAGs were subjected to 
antimicrobial evaluation against both bacterial 
and fungal strains and also for cytotoxicity assay 
against five cell lines. It was found that the MAGs 
showed antibacterial action but were not found to 
exhibit antifungal activity. The antibacterial activ-
ity was tested against both Gram-positive and 
Gram-negative bacterial strains. The results of 
the antibacterial activity were measured as zone 
of  inhibition (in mm) and are presented in Table 2. 
The Gram-positive strains used in the study were 
Staphylococcus aureus, Staphylococcus epidermi-
dis, Bacillus subtilis and the Gram-negative strains 
were Escherichia coli, Pseudomonas aeroginosa 
and Klebsiella pneumonia. Penicillin and strepto-
mycin were used as standard reference antibiotic 
Figure 1. Synthetic route for 1-monoolein. 
HO
O
O
DCC,DMAP
+
O
O
O
O
OH
O
O
O
OH
OH
MeOH/HCl, 0 - 30°C
5 hr
0 - 30°C, 24 hr
1b
2b
Table 1. Fatty acid composition (wt%) of substrate oils and their enriched fractions
Fatty acid SWO
ALA-rich fraction 
from SWO Borage oil
GLA-rich fraction 
from Borage oil Castor oil
Ricinoleic acid-rich 
fraction from castor oil
14:0 0.3 ± 0.06 - - - - -
16:0 24.9 ± 0.94 - 10.0 ±0.03 - 1.3 ±0.33 -
16:1 1.3 ± 0.16 - 0.1 ±0.01 - - -
18:0 3.8 ± 0.31 - 4.2 ±0.03 - 1.2 ±0.32 -
18:1 13.2 ± 0.27 1.1 ±0.01 17.0 ±0.07 - 4.3 ±1.01 0.3 ±0.03
18:2 4.2 ± 0.04 4.7 ±0.13 37.3 ±0.09 4.1 ±0.09 5.0 ±0.42 0.4 ±0.04
18:1-O - - - - 88.2 ±2.08 99.3 ±0.07
18:3-A 51.6 ±0.57 94.1 ±0.13 0.3 ±0.04 1.3 ±0.06 - -
18:3-G - - 22.4 ±0.03 94.6 ±0.04 - -
20:0 - - 0.2 ±0.01 - - -
20:1 - - 4.1 ±0.06 - - -
22:0 - - 0.2 ±0.01 - - -
22:1 - - 2.6 ±0.05 - - -
24:0 - - 1.5 ±0.01 - - -
SWO: silkworm oil; ALA: alpha linolenic acid: GLA: gamma linolenic acid ±, Standard deviation of mean value of triplicates using 
Graph Pad Prism software
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compounds and 1-monolaurin was used as lipidic 
reference. 
It was observed that most of the prepared 
1-MAGs were more effective against Gram-positive 
bacteria compared to Gram-negative bacteria. 
Among the lipids, GLA-MAG showed a broad 
spectrum antibacterial activity against all the tested 
strains except against Klebsiella pneumonia. When 
analyzing the susceptibility of the lipids against 
various bacterial strains according to zone of inhi-
bition, GLA-MAG against Staphylococcus aureu; 
ALA-MAG against Bacillus subtilis and Erucic-
MAG against Staphylococcus epidermidis exhibited 
higher antimicrobial action. To further investigate 
the efficacy of the prepared MAGs, minimum inhib-
itory concentration (MIC in µg/mL) was also deter-
mined (Table 3).
After the MAG of GLA, the next active MAG 
was observed to be of ALA, which showed inhibition 
against Staphylococcus aureus and Bacillus subtilis 
with MIC values of 37.5 and 9.37 µg/mL, respec-
tively. It was noted that the MAG of ricinoleic acid 
showed moderate activity against Staphylococcus 
aureus. In this study, the MAG of undecenoic acid 
was found to be active against two Gram-positive and 
one Gram-negative bacterial strains. The MIC value 
of UDA-MAG against Staphylococcus aureus in the 
present study was 150 µg/mL, which was compara-
ble to the value determined in a previously reported 
study (Dolezalova et al., 2010). It was reported that 
undecenoic acid was better known for its antifungal 
activity rather than antibacterial activity (Marijke 
and Stevens 2009). However, in the present study, it 
was found that MAGs with longer fatty acid chains 
were more effective compared to MAGs of unde-
cenoic acid in terms of zone of inhibition. Earlier 
studies also reported that an increase in unsatura-
tion of long-chain fatty acids has a positive effect 
on the antimicrobial action of fatty acids compared 
to saturated and shorter-chain fatty acids (Thormar 
and Hilmarsson 2007). It was interesting to observe 
that the MAG of erucic acid was active only against 
Staphylococcus epidermidis along with the MAG of 
Figure 3. Structures of the 1-monoacylglycerols. 
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Figure 2. Synthetic route for 1-monoricinolein. 
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GLA and no other MAG was effective against this 
bacteria, including monolaurin. The MIC value of 
the MAG of erucic acid was 9.37 µg/mL, whereas 
GLA-MAG showed an MIC of 37.5 µg/mL, which 
indicated that a very long-chain monounsaturated 
fatty acid was selectively active on this strain. In 
this study, GLA-MAG was observed to be the most 
active compound among all the MAGs tested. As 
monolaurin is the most widely known antimicrobial 
compound, we tried to compare the antimicrobial 
properties of the prepared MAGs with monolaurin. 
It was found that the MAG of GLA was more effec-
tive than 1-monolaurin against all the strains where 
monolaurin showed activity. Both zones of inhibi-
tions and the MIC values of GLA-MAG were bet-
ter than monolaurin. It was found that GLA-MAG 
was the most potent MAG against Bacillus subtilis 
with a MIC value of 4.74 µg/mL, which was better 
than standard streptomycin which showed an MIC 
value of 6.25 µg/mL. Many studies conducted ear-
lier also reported similar observations where several 
antimicrobial lipids were shown to exhibit greater 
activity against Gram-positive bacteria species over 
Gram-negative species (Yoon et al., 2018). Against 
Gram-negative bacteria viz Pseudomonas aerugi-
nosa, both GLA-MAG and UDA-MAG showed a 
Table 2. Bacterial zone of inhibition (mm) of test compounds 
Name of the Compound with code
Staphylococcus 
aureus
Staphylococcus 
epidermidis
Bacillus
subtilis
Escherichia 
coli
Pseudomonas 
aeruginosa
Klebsiella 
pneumoniae
1-Monolaurin (lipid reference 
standard)
15.8±0.7 - 18.8±0.7 15±1 18.33±0.5 -
2a (UDA-MAG) 11±0.5a - 8±1a - 19.66±0.5 ns -
2b (Oleic-MAG) - - - - - -
2c (Linoleic-MAG) - - - - - -
2d (GLA-MAG) 18.6±0.5 a 19.16±0.2 b 22.5±0.5a 18.6±0.5a 20.33±1.1c -
2e (ALA-MAG) 16.8±0.2 ns - 20.8±0.2 c - - -
2f (Erucic-MAG) - 20±0.5 b - - - -
2g (Ricinoleic-MAG) 11.6±0.5 a - - - - -
Penicillin (standard) 28±0.2 a 25.83±0.28 27.6±0.5a 24.16±0.7a 23.16±0.28a 25.33±0.5
Streptomycin 22.8±0.2 a 25.16±0.2 24±1a 23.3±0.5a 27.33±0.5a 26.16±0.2
±, Mean value with standard error of mean of triplicates; ‘‘One-way ANOVA’’ used to measure the mean differences among the 
compounds by the Dunnett’s multiple comparisons test. a Significantly different from (lipid reference standard, 1-Monolaurin) at 
P < 0.001; b Significantly different from Penicillin at P < 0.001; c Significantly different from (lipid reference standard, 1-Monolaurin) 
at P < 0.05; ns notsignificant 
Table 3. Minimum Inhibitory Concentration (µg/mL) of test compounds
Compound 
Staphylococcus 
aureus
Staphylococcus 
epidermidis
Bacillus
subtilis
Escherichia 
coli
Pseudomonas 
aeruginosa
Klebsiella 
pneumoniae
2a (UDA-MAG) 150 >150 150 >150 9.37 >150
2b (Oleic-MAG) >150 >150 >150 >150 >150 >150
2c (Linoleic-MAG) >150 >150 >150 >150 >150 >150
2d (GLA-MAG) 18.75 37.5 4.74 37.5 9.37 >150
2e (ALA-MAG) 37.5 >150 9.37 >150 >150 >150
2f (Erucic-MAG) >150 9.37 >150 >150 >150 >150
2g (Ricinoleic-MAG) 150 >150 >150 >150 >150 >150
1-Monolaurin 37.5 >150 18.75 37.5 18.75 >150
Standard Drug 
Penicillin 1.562 3.125 1.562 12.5 12.5 6.25
Streptomycin 6.25 3.125 6.25 6.25 1.562 3.125
Media values are represented in μg/mL of serial dilution of two replicates. For all the test compounds, the highest concentration was 
used at 150 μg/mL and lowest concentration used at 2.34 μg/mL; whereas, for standards (Penicillin and Strepotomycin) the highest 
concentration used at 100 μg/mL and lowest concentration at 0.78 μg/mL. Values with > 150 are considered to show no antibacterial 
activity.
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MIC value of 9.37 µg/mL, which is better than one 
of the standard antibiotic penicillins which showed 
a MIC of 12.5 µg/mL. Against E. coli, only GLA-
MAG exhibited moderate activity with a MIC of 
37.5 µg/mL, which was comparable to monolaurin 
but lower than both standard antibiotics. It was 
also found that monolaurin was not active against 
Staphylococcus epidermidis whereas GLA-MAG 
and erucic-MAG showed better activity against this 
strain compared to monolaurin with MIC values of 
37.5 and 9.37 µg/mL, respectively.
The cytotoxicity evaluation for the prepared 
MAGs was carried out by the widely employed 
MTT assay and the results are presented in Table 4. 
From the cytotoxicity assay, it can be observed that 
all of the MAGs were found to show moderate activ-
ity compared to the standard drug. However, the 
MAGs showed better activity against MCF-7 cell 
lines compared to the other cell lines. Each MAG 
showed different activity against different cell lines. 
According to their IC50 values, it was found that eru-
cic-MAG showed the highest activity against HeLa, 
ALA-MAG against B16-F10, ricinoleic-MAG 
against SKOV3, GLA-MAG against MCF-7 and 
the oleic MAG against CHO-K1. 
The present study was helpful in assessing the 
antimicrobial and cytotoxicity potential of the 
1-MAGs of some of the unsaturated fatty acids and 
further studies on a range of 1-MAGs of different 
fatty acids could be of interest in view of developing 
biocompatible biologically active agents. 
4. CONCLUSIONS
The synthesis of structured 1-monoacylglycerols 
comprising unsaturated fatty acids and their anti-
microbial and cytotoxicity efficacies were studied. 
Among the prepared lipid derivatives, the mono-
acylglycerol of gamma linolenic acid was found to 
be the most effective against both Gram-positive 
and Gram-negative bacterial strains. All the MAGs 
prepared exhibited moderate cytotoxicity activity 
against a panel of cell lines. However, further stud-
ies are needed to exploit the full potential of these 
monoacylglycerol derivatives with different types of 
fatty acids to test in food-based systems for addi-
tional applications.
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